ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC39653-100mg |
|
40348-72-9 |
Methyl 2-hydroxy-4-methylvalerate
|
0 | C7H14O3 | |
GC39653-10mg |
|
40348-72-9 |
Methyl 2-hydroxy-4-methylvalerate
|
0 | C7H14O3 | |
GC39652-250mg |
|
58-95-7 |
D-α-Tocopherol acetate
|
0 | C31H52O3 | |
GC39652-100mg |
|
58-95-7 |
D-α-Tocopherol acetate
|
0 | C31H52O3 | |
GC39651-250mg |
|
862892-90-8 |
GSK256073
|
0 | C10H13ClN4O2 | |
GC39651-100mg |
|
862892-90-8 |
GSK256073
|
0 | C10H13ClN4O2 | |
GC39651-50mg |
|
862892-90-8 |
GSK256073
|
0 | C10H13ClN4O2 | |
GC39651-10mg |
|
862892-90-8 |
GSK256073
|
0 | C10H13ClN4O2 | |
GC39651-5mg |
|
862892-90-8 |
GSK256073
|
0 | C10H13ClN4O2 | |
GC39650-100mg |
|
2143096-93-7 |
Navitoclax-piperazine
|
0 | C47H56ClF3N6O5S3 | |
GC39650-50mg |
|
2143096-93-7 |
Navitoclax-piperazine
|
0 | C47H56ClF3N6O5S3 | |
GC39650-10mg |
|
2143096-93-7 |
Navitoclax-piperazine
|
0 | C47H56ClF3N6O5S3 | |
GC39650-5mg |
|
2143096-93-7 |
Navitoclax-piperazine
|
0 | C47H56ClF3N6O5S3 | |
GC39649-100mg |
|
850330-18-6 |
ML604086
|
0 | C27H32N4O4S | |
GC39649-50mg |
|
850330-18-6 |
ML604086
|
0 | C27H32N4O4S | |
GC39649-10mg |
|
850330-18-6 |
ML604086
|
0 | C27H32N4O4S | |
GC39649-5mg |
|
850330-18-6 |
ML604086
|
0 | C27H32N4O4S | |
GC39648-100mg |
|
2194903-42-7 |
H3B-120
|
0 | C19H24N4O2S | |
GC39648-50mg |
|
2194903-42-7 |
H3B-120
|
0 | C19H24N4O2S | |
GC39648-10mg |
|
2194903-42-7 |
H3B-120
|
0 | C19H24N4O2S | |